As for hemophilia B, intravenous administration of rAAV8 and 9 carrying the IX factor gene in a murine model resulted in a significant increase in transgene expression and therefore in IX factor levels, with a decreased proinflammatory risk [168]. Here, F9 is linked to hemophilia B.